These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 36855180)

  • 1. A patient who recovered from post-COVID myalgic encephalomyelitis/chronic fatigue syndrome: a case report.
    Oka T
    Biopsychosoc Med; 2023 Feb; 17(1):8. PubMed ID: 36855180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
    Retornaz F; Rebaudet S; Stavris C; Jammes Y
    J Transl Med; 2022 Sep; 20(1):429. PubMed ID: 36153556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].
    Renz-Polster H; Scheibenbogen C
    Inn Med (Heidelb); 2022 Aug; 63(8):830-839. PubMed ID: 35925074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
    Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
    Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
    Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
    J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Campen CLMCV; Rowe PC; Visser FC
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
    [No Abstract]   [Full Text] [Related]  

  • 7. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Vernon SD; Hartle M; Sullivan K; Bell J; Abbaszadeh S; Unutmaz D; Bateman L
    Work; 2023; 74(4):1179-1186. PubMed ID: 36911963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
    Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
    Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
    Front Immunol; 2022; 13():949787. PubMed ID: 36341457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).
    Preßler H; Machule ML; Ufer F; Bünger I; Li LY; Buchholz E; Werner C; Beraha E; Wagner F; Metz M; Burock S; Bruckert L; Franke C; Wilck N; Krüger A; Reshetnik A; Eckardt KU; Endres M; Prüss H
    Trials; 2024 Mar; 25(1):172. PubMed ID: 38454468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue and symptom-based clusters in post COVID-19 patients: a multicentre, prospective, observational cohort study.
    Cornelissen MEB; Bloemsma LD; Vaes AW; Baalbaki N; Deng Q; Beijers RJHCG; Noij LCE; Houweling L; Bazdar S; Spruit MA; Maitland-van der Zee AH;
    J Transl Med; 2024 Feb; 22(1):191. PubMed ID: 38383493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
    Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
    J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lv Y; Zhang T; Cai J; Huang C; Zhan S; Liu J
    Front Immunol; 2022; 13():952987. PubMed ID: 36189286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
    medRxiv; 2022 Jan; ():. PubMed ID: 35043127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Typing myalgic encephalomyelitis by infection at onset: A DecodeME study.
    Bretherick AD; McGrath SJ; Devereux-Cooke A; Leary S; Northwood E; Redshaw A; Stacey P; Tripp C; Wilson J; Chowdhury S; Lewis I; Almelid Ø; Baby SV; Baker T; Becher H; Boutin T; Clyde M; Garcia D; Ireland J; Kerr SM; McDowall E; Perry D; Samms GL; Vitart V; Wolfe JC; Ponting CP
    NIHR Open Res; 2023; 3():20. PubMed ID: 37881452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long COVID in pediatrics-epidemiology, diagnosis, and management.
    Toepfner N; Brinkmann F; Augustin S; Stojanov S; Behrends U
    Eur J Pediatr; 2024 Apr; 183(4):1543-1553. PubMed ID: 38279014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.
    Twisk FN
    Front Physiol; 2014; 5():109. PubMed ID: 24734022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome.
    Chaves-Filho AM; Braniff O; Angelova A; Deng Y; Tremblay MÈ
    Brain Res Bull; 2023 Sep; 201():110702. PubMed ID: 37423295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
    Haffke M; Freitag H; Rudolf G; Seifert M; Doehner W; Scherbakov N; Hanitsch L; Wittke K; Bauer S; Konietschke F; Paul F; Bellmann-Strobl J; Kedor C; Scheibenbogen C; Sotzny F
    J Transl Med; 2022 Mar; 20(1):138. PubMed ID: 35317812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.